Correlation Between Molecular Partners and Evolva Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Evolva Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Evolva Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Evolva Holding SA, you can compare the effects of market volatilities on Molecular Partners and Evolva Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Evolva Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Evolva Holding.

Diversification Opportunities for Molecular Partners and Evolva Holding

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Molecular and Evolva is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Evolva Holding SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evolva Holding SA and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Evolva Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evolva Holding SA has no effect on the direction of Molecular Partners i.e., Molecular Partners and Evolva Holding go up and down completely randomly.

Pair Corralation between Molecular Partners and Evolva Holding

Assuming the 90 days trading horizon Molecular Partners AG is expected to under-perform the Evolva Holding. In addition to that, Molecular Partners is 1.01 times more volatile than Evolva Holding SA. It trades about -0.06 of its total potential returns per unit of risk. Evolva Holding SA is currently generating about 0.0 per unit of volatility. If you would invest  88.00  in Evolva Holding SA on August 29, 2024 and sell it today you would lose (3.00) from holding Evolva Holding SA or give up 3.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Molecular Partners AG  vs.  Evolva Holding SA

 Performance 
       Timeline  
Molecular Partners 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Molecular Partners AG are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Molecular Partners may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Evolva Holding SA 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Evolva Holding SA are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal technical and fundamental indicators, Evolva Holding may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Molecular Partners and Evolva Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Molecular Partners and Evolva Holding

The main advantage of trading using opposite Molecular Partners and Evolva Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Evolva Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolva Holding will offset losses from the drop in Evolva Holding's long position.
The idea behind Molecular Partners AG and Evolva Holding SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing